Cargando…
PI3K Pathway in NSCLC
The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of intracellular lipid kinases that phosphorylate the 3′-hydroxyl group of phosphatidylinositol and phosphoinositides. PI3K regulate signaling pathways for neoplasia, including cell proliferation, adhesion, survival, and motility. Di...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356073/ https://www.ncbi.nlm.nih.gov/pubmed/22655251 http://dx.doi.org/10.3389/fonc.2011.00055 |
_version_ | 1782233493906915328 |
---|---|
author | Martinez-Martí, Alex Felip, Enriqueta |
author_facet | Martinez-Martí, Alex Felip, Enriqueta |
author_sort | Martinez-Martí, Alex |
collection | PubMed |
description | The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of intracellular lipid kinases that phosphorylate the 3′-hydroxyl group of phosphatidylinositol and phosphoinositides. PI3K regulate signaling pathways for neoplasia, including cell proliferation, adhesion, survival, and motility. Different classes of PI3K have distinct roles in cellular signal transduction. PI3K pathway is activated by several different mechanisms in cancers, including, somatic mutation and gene amplification. In this review, we examine the literature addressing PI3K mutation status and gene amplification, with an emphasis on non-small cell lung cancer. |
format | Online Article Text |
id | pubmed-3356073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33560732012-05-31 PI3K Pathway in NSCLC Martinez-Martí, Alex Felip, Enriqueta Front Oncol Oncology The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of intracellular lipid kinases that phosphorylate the 3′-hydroxyl group of phosphatidylinositol and phosphoinositides. PI3K regulate signaling pathways for neoplasia, including cell proliferation, adhesion, survival, and motility. Different classes of PI3K have distinct roles in cellular signal transduction. PI3K pathway is activated by several different mechanisms in cancers, including, somatic mutation and gene amplification. In this review, we examine the literature addressing PI3K mutation status and gene amplification, with an emphasis on non-small cell lung cancer. Frontiers Research Foundation 2012-01-06 /pmc/articles/PMC3356073/ /pubmed/22655251 http://dx.doi.org/10.3389/fonc.2011.00055 Text en Copyright © 2012 Martinez-Martí and Felip. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited. |
spellingShingle | Oncology Martinez-Martí, Alex Felip, Enriqueta PI3K Pathway in NSCLC |
title | PI3K Pathway in NSCLC |
title_full | PI3K Pathway in NSCLC |
title_fullStr | PI3K Pathway in NSCLC |
title_full_unstemmed | PI3K Pathway in NSCLC |
title_short | PI3K Pathway in NSCLC |
title_sort | pi3k pathway in nsclc |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356073/ https://www.ncbi.nlm.nih.gov/pubmed/22655251 http://dx.doi.org/10.3389/fonc.2011.00055 |
work_keys_str_mv | AT martinezmartialex pi3kpathwayinnsclc AT felipenriqueta pi3kpathwayinnsclc |